{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T12:27:51Z","timestamp":1785414471326,"version":"3.56.0"},"reference-count":135,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009164","name":"Moffitt Cancer Center","doi-asserted-by":"crossref","award":["02-40000-26-23"],"award-info":[{"award-number":["02-40000-26-23"]}],"id":[{"id":"10.13039\/100009164","id-type":"DOI","asserted-by":"crossref"}]},{"award":["02-40000-26-23"],"award-info":[{"award-number":["02-40000-26-23"]}],"id":[{"id":"https:\/\/ror.org\/01xf75524","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background: Androgen deprivation therapy (ADT) is widely used in the management of prostate cancer (PCa) and remains a cornerstone of treatment across multiple disease settings. Although ADT contributes substantially to disease control, it also induces significant adverse metabolic and body composition changes. These alterations include loss of lean mass, increased fat mass, and deterioration in muscle quality, together contributing to a clinical phenotype consistent with sarcopenic obesity (SO). Importantly, ADT-induced SO is characterized not only by reductions in skeletal muscle mass but also by impaired muscle quality, particularly the fatty infiltration of skeletal muscle, or myosteatosis, an underrecognized but defining feature of this syndrome. Methods: This narrative review examines current evidence regarding interventions aimed at mitigating sarcopenic obesity in men treated with ADT for prostate cancer, identifies key gaps in the literature, and proposes a mechanism-driven path forward for intervention development. Results: Several exercise- and nutrition-based interventions have been evaluated in men receiving ADT and demonstrate improvements in selected outcomes such as muscle strength, body composition, and metabolic parameters. However, most studies have been limited by small sample sizes, short intervention durations, and a focus on isolated intervention components. Importantly, muscle quality and intramuscular fat infiltration (myosteatosis), a central component of sarcopenic obesity, have rarely been incorporated as biomarkers or endpoints in intervention trials targeting men receiving ADT. Conclusions: Future interventions designed to mitigate SO and its associated metabolic abnormalities should evaluate comprehensive, bundled strategies initiated early during ADT and sustained long enough to capture clinically meaningful changes. Outcomes should include biomarkers of muscle mass, strength, and quality, including imaging-based measures of myosteatosis, along with metabolic syndrome markers, inflammatory mediators, functional outcomes, adherence, and quality of life. These changes should evaluate the correlation with underlying biological mechanisms such as NF-\u03baB signaling and pro-inflammatory cytokines. Such data may inform future phase III trials and ultimately support clinical strategies to mitigate ADT-related sarcopenic obesity and its downstream cardiometabolic and oncologic consequences.<\/jats:p>","DOI":"10.3390\/cancers18081276","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T10:11:04Z","timestamp":1776420664000},"page":"1276","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Myosteatosis and Sarcopenic Obesity in Men Receiving Androgen Deprivation Therapy for Prostate Cancer: Rationale for Mechanism-Driven Multimodal Intervention"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6121-2627","authenticated-orcid":false,"given":"Nagi B.","family":"Kumar","sequence":"first","affiliation":[{"name":"Cancer Epidemiology Program, Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA"},{"name":"Genitourinary Oncology Program, Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8947-7942","authenticated-orcid":false,"given":"Nathan","family":"Parker","sequence":"additional","affiliation":[{"name":"Health Outcomes and Behavior Program, Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1192-5116","authenticated-orcid":false,"given":"Jingsong","family":"Zhang","sequence":"additional","affiliation":[{"name":"Genitourinary Oncology Program, Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"Pow-Sang","sequence":"additional","affiliation":[{"name":"Genitourinary Oncology Program, Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6384-6447","authenticated-orcid":false,"given":"Jong Y.","family":"Park","sequence":"additional","affiliation":[{"name":"Cancer Epidemiology Program, Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA"},{"name":"Genitourinary Oncology Program, Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4594-6601","authenticated-orcid":false,"given":"Michael J.","family":"Schell","sequence":"additional","affiliation":[{"name":"Biostatistics and Bioinformatics Program, Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,4,17]]},"reference":[{"key":"ref_1","unstructured":"American Cancer Society (2025). Cancer Facts & Figures 2026, American Cancer Society."},{"key":"ref_2","first-page":"293","article-title":"Studies on Prostatic Cancer I. The Effect of Castration, of Estrogen and of Androgen Injection on Serum Phosphatases in Metastatic Carcinoma of the Prostate","volume":"1","author":"Huggins","year":"1941","journal-title":"Cancer Res."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.urolonc.2009.09.004","article-title":"Prevalent and incident use of androgen deprivation therapy among men with prostate cancer in the United States","volume":"29","author":"Gilbert","year":"2011","journal-title":"Urol. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1038\/bjc.2011.385","article-title":"Androgen deprivation therapy as adjuvant\/neoadjuvant to radiotherapy for high-risk localised and locally advanced prostate cancer: Recent developments","volume":"105","author":"Payne","year":"2011","journal-title":"Br. J. Cancer"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"101594","DOI":"10.1016\/j.jgo.2023.101594","article-title":"The trajectory of sarcopenia following diagnosis of prostate cancer: A systematic review and meta-analysis","volume":"14","author":"Pavlin","year":"2023","journal-title":"J. Geriatr. Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1097\/JU.0000000000001873","article-title":"Sarcopenic Obesity and its Prognostic Impact on Urological Cancers: A Systematic Review","volume":"206","author":"Mari","year":"2021","journal-title":"J. Urol."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Stelmach-Mardas, M., Warcho\u0142, W., Garczyk, A., Warcho\u0142, E., Korczak, J., Litwiniuk, M., Brajer-Luftmann, B., and Mardas, M. (2024). Influence of Androgen Deprivation Therapy on the Development of Sarcopenia in Patients with Prostate Cancer: A Systematic Review. Nutrients, 16.","DOI":"10.20944\/preprints202401.1559.v1"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Wilson, R.L., Taaffe, D.R., Newton, R.U., Hart, N.H., Lyons-Wall, P., and Galv\u00e3o, D.A. (2021). Using Exercise and Nutrition to Alter Fat and Lean Mass in Men with Prostate Cancer Receiving Androgen Deprivation Therapy: A Narrative Review. Nutrients, 13.","DOI":"10.3390\/nu13051664"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/iju.13473","article-title":"Metabolic changes in patients with prostate cancer during androgen deprivation therapy","volume":"25","author":"Mitsuzuka","year":"2018","journal-title":"Int. J. Urol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.euf.2021.04.022","article-title":"Role of Metabolic Syndrome in Prostate Cancer Development","volume":"7","author":"Lifshitz","year":"2021","journal-title":"Eur. Urol. Focus."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.jgo.2019.03.017","article-title":"Presence of sarcopenic obesity and evaluation of the associated muscle quality in Japanese older men with prostate cancer undergoing androgen deprivation therapy","volume":"10","author":"Kimura","year":"2019","journal-title":"J. Geriatr. Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1159\/000521241","article-title":"Definition and Diagnostic Criteria for Sarcopenic Obesity: ESPEN and EASO Consensus Statement","volume":"15","author":"Donini","year":"2022","journal-title":"Obes. Facts"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/s41574-018-0062-9","article-title":"Sarcopenic obesity in older adults: Aetiology, epidemiology and treatment strategies","volume":"14","author":"Batsis","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1615\/CritRevBiomedEng.2020031124","article-title":"Impact of Inter- and Intramuscular Fat on Muscle Architecture and Capacity","volume":"47","author":"Jiang","year":"2019","journal-title":"Crit. Rev. Biomed. Eng."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Kumar, N.B. (2026). Myosteatosis: A Distinct, Early and Targetable Novel Biomarker of Cancer Prognosis. Cancers, 18.","DOI":"10.3390\/cancers18060974"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/jcsm.12357","article-title":"The relationship between computed tomography-derived body composition, systemic inflammatory response, and survival in patients undergoing surgery for colorectal cancer","volume":"10","author":"Dolan","year":"2019","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"5081","DOI":"10.1210\/en.2003-0741","article-title":"Androgens stimulate myogenic differentiation and inhibit adipogenesis in C3H 10T1\/2 pluripotent cells through an androgen receptor-mediated pathway","volume":"144","author":"Singh","year":"2003","journal-title":"Endocrinology"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Zhao, T., Mao, W., Hu, M., Yu, Q., Peng, X., Ji, J., Qiu, J., and Wu, J. (2024). Advances in sarcopenia and urologic disorders. Front. Nutr., 11.","DOI":"10.3389\/fnut.2024.1475977"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1111\/j.1464-410X.2007.07184.x","article-title":"Risk of new-onset diabetes mellitus and worsening glycaemic variables for established diabetes in men undergoing androgen-deprivation therapy for prostate cancer","volume":"100","author":"Derweesh","year":"2007","journal-title":"BJU Int."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1210\/clinem\/dgad450","article-title":"New Horizons: Epidemiology of Obesity, Diabetes Mellitus, and Cancer Prognosis","volume":"109","author":"Harborg","year":"2024","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"299.e10","DOI":"10.1016\/j.clgc.2022.01.016","article-title":"Association of Obesity and Diabetes With Prostate Cancer Risk Groups in a Multiethnic Population","volume":"20","author":"Zhu","year":"2022","journal-title":"Clin. Genitourin. Cancer"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/s41391-021-00481-7","article-title":"Obesity and biochemical recurrence in clinically localised prostate cancer: A systematic review and meta-analysis of 86,490 patients","volume":"25","year":"2022","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1200\/JCO.19.02185","article-title":"Postdiagnosis Body Mass Index, Weight Change, and Mortality From Prostate Cancer, Cardiovascular Disease, and All Causes Among Survivors of Nonmetastatic Prostate Cancer","volume":"38","author":"Troeschel","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1186\/1745-6215-15-354","article-title":"The Individualized Diet and Exercise Adherence Pilot Trial (IDEA-P) in prostate cancer patients undergoing androgen deprivation therapy: Study protocol for a randomized controlled trial","volume":"15","author":"Focht","year":"2014","journal-title":"Trials"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/abm\/kax002","article-title":"Effects of a Group-Mediated Exercise and Dietary Intervention in the Treatment of Prostate Cancer Patients Undergoing Androgen Deprivation Therapy: Results From the IDEA-P Trial","volume":"52","author":"Focht","year":"2018","journal-title":"Ann. Behav. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1249\/MSS.0000000000003095","article-title":"Resistance Exercise Training Increases Muscle Mass and Strength in Prostate Cancer Patients on Androgen Deprivation Therapy","volume":"55","author":"Houben","year":"2023","journal-title":"Med. Sci. Sports Exerc."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"pkad070","DOI":"10.1093\/jncics\/pkad070","article-title":"Advancing the science of integrating multiple interventions by blending and bundling","volume":"7","author":"Villalobos","year":"2023","journal-title":"JNCI Cancer Spectr."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1007\/s12272-021-01349-z","article-title":"Understanding of sarcopenia: From definition to therapeutic strategies","volume":"44","author":"Kim","year":"2021","journal-title":"Arch. Pharm. Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/sj.bjc.6601132","article-title":"Increased expression of the ubiquitin-proteasome pathway in murine myotubes by proteolysis-inducing factor (PIF) is associated with activation of the transcription factor NF-kappaB","volume":"89","author":"Whitehouse","year":"2003","journal-title":"Br. J. Cancer"},{"key":"ref_30","first-page":"805","article-title":"Mechanisms of skeletal muscle degradation and its therapy in cancer cachexia","volume":"22","author":"Melstrom","year":"2007","journal-title":"Histol. Histopathol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/S0140-6736(00)04177-5","article-title":"Transcription factors and muscle cachexia: Is there a therapeutic target?","volume":"357","author":"Mitch","year":"2001","journal-title":"Lancet"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/(SICI)1097-4644(2000)77:34+<40::AID-JCB9>3.0.CO;2-6","article-title":"The ubiquitin-mediated proteolytic pathway: Mode of action and clinical implications","volume":"34","author":"Ciechanover","year":"2000","journal-title":"J. Cell Biochem. Suppl."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1002\/jcsm.12901","article-title":"Pathogenesis of sarcopenia and the relationship with fat mass: Descriptive review","volume":"13","author":"Li","year":"2022","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"7863","DOI":"10.1096\/fj.201802457RR","article-title":"Reduced mitochondrial lipid oxidation leads to fat accumulation in myosteatosis","volume":"33","author":"Gumucio","year":"2019","journal-title":"FASEB J."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"100963","DOI":"10.1016\/j.jhepr.2023.100963","article-title":"Myosteatosis: Diagnosis, pathophysiology and consequences in metabolic dysfunction-associated steatotic liver disease","volume":"6","author":"Henin","year":"2023","journal-title":"JHEP Rep."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/ncb2014","article-title":"Mesenchymal progenitors distinct from satellite cells contribute to ectopic fat cell formation in skeletal muscle","volume":"12","author":"Uezumi","year":"2010","journal-title":"Nat. Cell Biol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/387083a0","article-title":"Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member","volume":"387","author":"McPherron","year":"1997","journal-title":"Nature"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.cell.2010.07.011","article-title":"Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival","volume":"142","author":"Zhou","year":"2010","journal-title":"Cell"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1038\/ng.2772","article-title":"BMP signaling controls muscle mass","volume":"45","author":"Sartori","year":"2013","journal-title":"Nat. Genet."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1530\/EJE-16-0868","article-title":"Testosterone prevents protein loss via the hepatic urea cycle in human","volume":"176","author":"Lam","year":"2017","journal-title":"Eur. J. Endocrinol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1210\/jc.2010-2521","article-title":"Interaction between testosterone and growth hormone on whole-body protein anabolism occurs in the liver","volume":"96","author":"Birzniece","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1530\/EC-19-0179","article-title":"A potent liver-mediated mechanism for loss of muscle mass during androgen deprivation therapy","volume":"8","author":"Lam","year":"2019","journal-title":"Endocr. Connect."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.coph.2020.06.003","article-title":"Myokines and adipokines in sarcopenia: Understanding cross-talk between skeletal muscle and adipose tissue and the role of exercise","volume":"52","author":"Paris","year":"2020","journal-title":"Curr. Opin. Pharmacol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1007\/s00018-011-0883-3","article-title":"Androgens and skeletal muscle: Cellular and molecular action mechanisms underlying the anabolic actions","volume":"69","author":"Dubois","year":"2012","journal-title":"Cell Mol. Life Sci."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"101277","DOI":"10.1016\/j.mam.2024.101277","article-title":"Fibro-adipogenic progenitors in physiological adipogenesis and intermuscular adipose tissue remodeling","volume":"97","author":"Kopinke","year":"2024","journal-title":"Mol. Aspects Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0022-5347(05)68000-7","article-title":"Progressive osteoporosis during androgen deprivation therapy for prostate cancer","volume":"163","author":"Daniell","year":"2000","journal-title":"J. Urol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1056\/NEJMoa010845","article-title":"Pamidronate to prevent bone loss during androgen-deprivation therapy for prostate cancer","volume":"345","author":"Smith","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"e433126","DOI":"10.1200\/EDBK_433126","article-title":"Balancing Hormone Therapy: Mitigating Adverse Effects of Androgen-Deprivation Therapy and Exploring Alternatives in Prostate Cancer Management","volume":"44","author":"Gudenkauf","year":"2024","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"},{"key":"ref_49","first-page":"dgaf302","article-title":"A Review of Hot Flash Management in Patients with Prostate Cancer","volume":"21","author":"Lin","year":"2025","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1634\/theoncologist.2012-0051","article-title":"Calcium and vitamin D supplementation during androgen deprivation therapy for prostate cancer: A critical review","volume":"17","author":"Datta","year":"2012","journal-title":"Oncologist"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/ncpuro1104","article-title":"Can exercise ameliorate the increased risk of cardiovascular disease and diabetes associated with ADT?","volume":"5","author":"Newton","year":"2008","journal-title":"Nat. Clin. Pract. Urol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/s41391-021-00363-y","article-title":"Body weight, fat mass and metabolic complications during androgen deprivation therapy: Should urologists recommend exercise and diet to help patients overcome toxicities?","volume":"24","author":"Taaffe","year":"2021","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1249\/MSS.0000000000002585","article-title":"Resistance Training Load Effects on Muscle Hypertrophy and Strength Gain: Systematic Review and Network Meta-analysis","volume":"53","author":"Lopez","year":"2021","journal-title":"Med. Sci. Sports Exerc."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/s41391-021-00442-0","article-title":"Associations of fat and muscle mass with overall survival in men with prostate cancer: A systematic review with meta-analysis","volume":"25","author":"Lopez","year":"2022","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1249\/MSS.0000000000002843","article-title":"Interventions for Improving Body Composition in Men with Prostate Cancer: A Systematic Review and Network Meta-analysis","volume":"54","author":"Lopez","year":"2022","journal-title":"Med. Sci. Sports Exerc."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1249\/MSS.0000000000001277","article-title":"Exercise Improves V\u02d9O2max and Body Composition in Androgen Deprivation Therapy-treated Prostate Cancer Patients","volume":"49","author":"Wall","year":"2017","journal-title":"Med. Sci. Sports Exerc."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1158\/2326-6066.CIR-22-0487","article-title":"Influence of Adipose Tissue Distribution, Sarcopenia, and Nutritional Status on Clinical Outcomes After CD19 CAR T-cell Therapy","volume":"11","author":"Rejeski","year":"2023","journal-title":"Cancer Immunol. Res."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"7224","DOI":"10.1182\/blood-2024-208557","article-title":"Exercise Prehabilitation for Older Adults Undergoing CAR-T: Feasibility and Preliminary Outcomes from a Single-Arm Pilot Study","volume":"144","author":"Parker","year":"2024","journal-title":"Blood"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/SLA.0000000000005878","article-title":"Effects of a Pragmatic Home-based Exercise Program Concurrent With Neoadjuvant Therapy on Physical Function of Patients With Pancreatic Cancer: The PancFit Randomized Clinical Trial","volume":"278","author":"Parker","year":"2023","journal-title":"Ann. Surg."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.ccell.2022.05.006","article-title":"Exercise-induced engagement of the IL-15\/IL-15R\u03b1 axis promotes anti-tumor immunity in pancreatic cancer","volume":"40","author":"Kurz","year":"2022","journal-title":"Cancer Cell"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1177\/1559827618759478","article-title":"Integrating Physical Activity Into Clinical Cancer Care","volume":"12","author":"Parker","year":"2018","journal-title":"Am. J. Lifestyle Med."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.numecd.2007.10.002","article-title":"Sarcopenic obesity: A new category of obesity in the elderly","volume":"18","author":"Zamboni","year":"2008","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Veen, J., Montiel-Rojas, D., Nilsson, A., and Kadi, F. (2021). Engagement in Muscle-Strengthening Activities Lowers Sarcopenia Risk in Older Adults Already Adhering to the Aerobic Physical Activity Guidelines. Int. J. Environ. Res. Public Health, 18.","DOI":"10.3390\/ijerph18030989"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s11864-010-0127-z","article-title":"Cancer cachexia: Traditional therapies and novel molecular mechanism-based approaches to treatment","volume":"11","author":"Kumar","year":"2010","journal-title":"Curr. Treat. Options Oncol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1146\/annurev.biochem.68.1.1015","article-title":"The 26S proteasome: A molecular machine designed for controlled proteolysis","volume":"68","author":"Voges","year":"1999","journal-title":"Annu. Rev. Biochem."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1016\/S0092-8674(02)00703-1","article-title":"Missing pieces in the NF-kappaB puzzle","volume":"109","author":"Ghosh","year":"2002","journal-title":"Cell"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.exger.2007.03.003","article-title":"Aging in adipocytes: Potential impact of inherent, depot-specific mechanisms","volume":"42","author":"Cartwright","year":"2007","journal-title":"Exp. Gerontol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.arr.2016.09.008","article-title":"Sarcopenic obesity or obese sarcopenia: A cross talk between age-associated adipose tissue and skeletal muscle inflammation as a main mechanism of pathogenesis","volume":"35","author":"Kalinkovich","year":"2017","journal-title":"Ageing Res. Rev."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.2174\/0929867326666181129095309","article-title":"Role of Pro-inflammatory Cytokines in Regulation of Skeletal Muscle Metabolism: A Systematic Review","volume":"27","author":"Sharma","year":"2020","journal-title":"Curr. Med. Chem."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"111931","DOI":"10.1016\/j.exger.2022.111931","article-title":"Inflammaging: The ground for sarcopenia?","volume":"168","author":"Liang","year":"2022","journal-title":"Exp. Gerontol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12979-024-00458-9","article-title":"Harnessing immunomodulation to combat sarcopenia: Current insights and possible approaches","volume":"21","author":"Zhang","year":"2024","journal-title":"Immun. Ageing"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1080\/07315724.2015.1080105","article-title":"Anti-inflammatory Diets","volume":"34","author":"Sears","year":"2015","journal-title":"J. Am. Coll. Nutr."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.jamda.2013.05.021","article-title":"Evidence-based recommendations for optimal dietary protein intake in older people: A position paper from the PROT-AGE Study Group","volume":"14","author":"Bauer","year":"2013","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.clnu.2008.06.008","article-title":"Optimal protein intake in the elderly","volume":"27","author":"Wolfe","year":"2008","journal-title":"Clin. Nutr."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.clnu.2014.04.007","article-title":"Protein intake and exercise for optimal muscle function with aging: Recommendations from the ESPEN Expert Group","volume":"33","author":"Deutz","year":"2014","journal-title":"Clin. Nutr."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.clnu.2012.08.015","article-title":"Impact of protein pulse feeding on lean mass in malnourished and at-risk hospitalized elderly patients: A randomized controlled trial","volume":"32","author":"Bouillanne","year":"2013","journal-title":"Clin. Nutr."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12937-017-0229-6","article-title":"Effect of a high protein diet and\/or resistance exercise on the preservation of fat free mass during weight loss in overweight and obese older adults: A randomized controlled trial","volume":"16","author":"Verreijen","year":"2017","journal-title":"Nutr. J."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Prokopidis, K., Cervo, M.M., Gandham, A., and Scott, D. (2020). Impact of Protein Intake in Older Adults with Sarcopenia and Obesity: A Gut Microbiota Perspective. Nutrients, 12.","DOI":"10.3390\/nu12082285"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"106850","DOI":"10.1016\/j.micpath.2024.106850","article-title":"Age-related sarcopenia and altered gut microbiota: A systematic review","volume":"195","author":"Wang","year":"2024","journal-title":"Microb. Pathog."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.clnu.2025.07.033","article-title":"Dietary protein intake and body composition, sarcopenia and sarcopenic obesity: A prospective population-based study","volume":"53","author":"Wu","year":"2025","journal-title":"Clin. Nutr."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0090-4295(01)01251-1","article-title":"Osteoporosis due to androgen deprivation therapy in men with prostate cancer","volume":"58","author":"Daniell","year":"2001","journal-title":"Urology"},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Jones, J.M., Tsang, D.S., Zheng, S., Yeheskel, A., Catton, C.N., Cheung, A.M., Hamilton, R., and Alibhai, S.M.H. (2022). Implementing and Evaluating the Impact of BoneRx: A Healthy Bone Prescription for Men with Prostate Cancer Initiating Androgen Deprivation Therapy. J. Clin. Med., 11.","DOI":"10.3390\/jcm11102703"},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Hassan-Smith, Z.K., Jenkinson, C., Smith, D.J., Hernandez, I., Morgan, S.A., Crabtree, N.J., and Hewison, M. (2017). 25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 exert distinct effects on human skeletal muscle function and gene expression. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0170665"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"6977","DOI":"10.3390\/md13116977","article-title":"Omega-3 Fatty Acids and Skeletal Muscle Health","volume":"13","author":"Jeromson","year":"2015","journal-title":"Mar. Drugs"},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Lee, J.H., Jeon, J.H., and Lee, M.J. (2020). Docosahexaenoic Acid, a Potential Treatment for Sarcopenia, Modulates the Ubiquitin-Proteasome and the Autophagy-Lysosome Systems. Nutrients, 12.","DOI":"10.3390\/nu12092597"},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Taheri, M., Chilibeck, P.D., and Cornish, S.M. (2023). A Brief Narrative Review of the Underlying Mechanisms Whereby Omega-3 Fatty Acids May Influence Skeletal Muscle: From Cell Culture to Human Interventions. Nutrients, 15.","DOI":"10.3390\/nu15132926"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.bbrc.2013.02.041","article-title":"The effect of eicosapentaenoic and docosahexaenoic acid on protein synthesis and breakdown in murine C2C12 myotubes","volume":"432","author":"Kamolrat","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_88","first-page":"CD004597","article-title":"Eicosapentaenoic acid (EPA, an omega-3 fatty acid from fish oils) for the treatment of cancer cachexia","volume":"24","author":"Dewey","year":"2007","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"M511","DOI":"10.1093\/gerona\/57.8.M511","article-title":"Molecular-based therapeutic approaches in treatment of anorexia of aging and cancer cachexia","volume":"57","author":"Hamerman","year":"2002","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"ref_90","first-page":"9455","article-title":"Does omega-3 PUFAs supplementation improve metabolic syndrome and related cardiovascular diseases? A systematic review and meta-analysis of randomized controlled trials","volume":"64","author":"Wang","year":"2024","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1080\/10408398.2021.1984199","article-title":"Does omega-3 PUFA-enriched oral nutritional intervention benefit cancer patients receiving chemo (radio) therapy? A systematic review and meta-analysis of randomized controlled trials","volume":"63","author":"Wang","year":"2023","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"e0472","DOI":"10.1097\/MD.0000000000010472","article-title":"Effect of \u03c9-3 polyunsaturated fatty acid-supplemented parenteral nutrition on inflammatory and immune function in postoperative patients with gastrointestinal malignancy: A meta-analysis of randomized control trials in China","volume":"97","author":"Zhao","year":"2018","journal-title":"Medicine"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1017\/S0007114522000575","article-title":"n-3 PUFA can reduce IL-6 and TNF levels in patients with cancer","volume":"129","author":"Guo","year":"2023","journal-title":"Br. J. Nutr."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1039\/D0FO01976C","article-title":"The effects of low-ratio n-6\/n-3 PUFA on biomarkers of inflammation: A systematic review and meta-analysis","volume":"12","author":"Wei","year":"2021","journal-title":"Food Funct."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"102959","DOI":"10.1016\/j.canep.2025.102959","article-title":"Nutritional intake of \u03c9-3 fatty acid intake and clinical grade of prostate cancer","volume":"99","author":"Kumar","year":"2025","journal-title":"Cancer Epidemiol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"S276","DOI":"10.1016\/j.semcancer.2015.09.007","article-title":"Designing a broad-spectrum integrative approach for cancer prevention and treatment","volume":"35","author":"Block","year":"2015","journal-title":"Semin. Cancer Biol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1016\/j.semcancer.2015.03.001","article-title":"Broad targeting of resistance to apoptosis in cancer","volume":"35","author":"Mohammad","year":"2015","journal-title":"Semin. Cancer Biol."},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Kumar, N.B. (2024). Contemporary Strategies for Clinical Chemoprevention of Localized Prostate Cancer. Cancer Control, epub ahead of print.","DOI":"10.1177\/10732748241302863"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.18632\/oncotarget.27529","article-title":"A phase II randomized clinical trial using aglycone isoflavones to treat patients with localized prostate cancer in the pre-surgical period prior to radical prostatectomy","volume":"11","author":"Kumar","year":"2020","journal-title":"Oncotarget"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"35412","DOI":"10.18632\/oncotarget.16015","article-title":"Sulforaphane for the chemoprevention of bladder cancer: Molecular mechanism targeted approach","volume":"8","author":"Leone","year":"2017","journal-title":"Oncotarget"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s11864-021-00865-w","article-title":"The Promise of Nutrient-Derived Bioactive Compounds and Dietary Components to Ameliorate Symptoms of Chemotherapy-Related Cognitive Impairment in Breast Cancer Survivors","volume":"22","author":"Kumar","year":"2021","journal-title":"Curr. Treat. Options Oncol."},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Barreca, M.M., Alessandro, R., and Corrado, C. (2023). Effects of Flavonoids on Cancer, Cardiovascular and Neurodegenerative Diseases: Role of NF-\u03baB Signaling Pathway. Int. J. Mol. Sci., 24.","DOI":"10.20944\/preprints202305.0824.v1"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1055\/s-0030-1250111","article-title":"Targeting inflammatory pathways by flavonoids for prevention and treatment of cancer","volume":"76","author":"Prasad","year":"2010","journal-title":"Planta Med."},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Al-Khayri, J.M., Sahana, G.R., Nagella, P., Joseph, B.V., Alessa, F.M., and Al-Mssallem, M.Q. (2022). Flavonoids as Potential Anti-Inflammatory Molecules: A Review. Molecules, 27.","DOI":"10.3390\/molecules27092901"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1017\/S002966511000162X","article-title":"Flavonoids as anti-inflammatory agents","volume":"69","author":"Serafini","year":"2010","journal-title":"Proc. Nutr. Soc."},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Ullah, A., Munir, S., Badshah, S.L., Khan, N., Ghani, L., Poulson, B.G., Emwas, A.H., and Jaremko, M. (2020). Important Flavonoids and Their Role as a Therapeutic Agent. Molecules, 25.","DOI":"10.3390\/molecules25225243"},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Saleh, H.A., Yousef, M.H., and Abdelnaser, A. (2021). The Anti-Inflammatory Properties of Phytochemicals and Their Effects on Epigenetic Mechanisms Involved in TLR4\/NF-\u03baB-Mediated Inflammation. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.606069"},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Laurindo, L.F., Santos, A.R.O.D., Carvalho, A.C.A., Bechara, M.D., Guiguer, E.L., Goulart, R.A., Vargas Sinatora, R., Ara\u00fajo, A.C., and Barbalho, S.M. (2023). Phytochemicals and Regulation of NF-kB in Inflammatory Bowel Diseases: An Overview of In Vitro and In Vivo Effects. Metabolites, 13.","DOI":"10.3390\/metabo13010096"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1080\/01635581.2012.630158","article-title":"New insights into the mechanisms of green tea catechins in the chemoprevention of prostate cancer","volume":"64","author":"Connors","year":"2012","journal-title":"Nutr. Cancer"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1158\/1940-6207.CAPR-14-0324","article-title":"Randomized, Placebo-Controlled Trial of Green Tea Catechins for Prostate Cancer Prevention","volume":"8","author":"Kumar","year":"2015","journal-title":"Cancer Prev. Res."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1158\/1940-6207.CAPR-13-0427-T","article-title":"Safety and chemopreventive effect of Polyphenon E in preventing early and metastatic progression of prostate cancer in TRAMP mice","volume":"7","author":"Kim","year":"2014","journal-title":"Cancer Prev. Res."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"70794","DOI":"10.18632\/oncotarget.12222","article-title":"Randomized, placebo-controlled trial evaluating the safety of one-year administration of green tea catechins","volume":"7","author":"Kumar","year":"2016","journal-title":"Oncotarget"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"C1258","DOI":"10.1152\/ajpcell.00105.2009","article-title":"Myostatin reduces Akt\/TORC1\/p70S6K signaling, inhibiting myoblast differentiation and myotube size","volume":"296","author":"Trendelenburg","year":"2009","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"113256","DOI":"10.1016\/j.biopha.2022.113256","article-title":"Medicinal uses, pharmacological activities, phytochemistry, and the molecular mechanisms of Punica granatum L. (pomegranate) plant extracts: A review","volume":"153","author":"Maphetu","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Cordiano, R., Gammeri, L., Di Salvo, E., Gangemi, S., and Minciullo, P.L. (2024). Pomegranate (Punica granatum L.) Extract Effects on Inflammaging. Molecules, 29.","DOI":"10.3390\/molecules29174174"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.jnutbio.2007.11.006","article-title":"Pomegranate polyphenols down-regulate expression of androgen-synthesizing genes in human prostate cancer cells overexpressing the androgen receptor","volume":"19","author":"Hong","year":"2008","journal-title":"J. Nutr. Biochem."},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"Livingstone, T.L., Saha, S., Bernuzzi, F., Savva, G.M., Troncoso-Rey, P., Traka, M.H., Mills, R.D., Ball, R.Y., and Mithen, R.F. (2022). Accumulation of Sulforaphane and Alliin in Human Prostate Tissue. Nutrients, 14.","DOI":"10.3390\/nu14163263"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.arr.2016.10.005","article-title":"Impact of intermittent fasting on health and disease processes","volume":"39","author":"Mattson","year":"2017","journal-title":"Ageing Res. Rev."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.cmet.2016.06.001","article-title":"Fasting, Circadian Rhythms, and Time-Restricted Feeding in Healthy Lifespan","volume":"23","author":"Longo","year":"2016","journal-title":"Cell Metab."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"3493S","DOI":"10.1093\/jn\/134.12.3493S","article-title":"Indole-3-carbinol and prostate cancer","volume":"134","author":"Sarkar","year":"2004","journal-title":"J. Nutr."},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Soundararajan, P., and Kim, J.S. (2018). Anti-Carcinogenic Glucosinolates in Cruciferous Vegetables and Their Antagonistic Effects on Prevention of Cancers. Molecules, 23.","DOI":"10.3390\/molecules23112983"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"5435","DOI":"10.1002\/ptr.7983","article-title":"Mechanism insights of curcumin and its analogues in cancer: An update","volume":"37","author":"Joshi","year":"2023","journal-title":"Phytother. Res."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1042\/CS20160935","article-title":"Curcumin mediates anticancer effects by modulating multiple cell signaling pathways","volume":"131","author":"Kunnumakkara","year":"2017","journal-title":"Clin. Sci."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"4779","DOI":"10.2174\/1381612825666190116124233","article-title":"Cruciferous Vegetables as Antioxidative, Chemopreventive and Antineoplasic Functional Foods: Preclinical and Clinical Evidences of Sulforaphane Against Prostate Cancers","volume":"24","author":"Ferreira","year":"2018","journal-title":"Curr. Pharm. Des."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.cmet.2015.05.012","article-title":"APeriodic Diet that Mimics Fasting Promotes Multi-System Regeneration, Enhanced Cognitive Performance, and Healthspan","volume":"22","author":"Brandhorst","year":"2015","journal-title":"Cell Metab."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"eaai8700","DOI":"10.1126\/scitranslmed.aai8700","article-title":"Fasting-mimicking diet and markers\/risk factors for aging, diabetes, cancer, and cardiovascular disease","volume":"9","author":"Wei","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.cmet.2015.09.005","article-title":"A Smartphone App Reveals Erratic Diurnal Eating Patterns in Humans that Can Be Modulated for Health Benefits","volume":"22","author":"Gill","year":"2015","journal-title":"Cell Metab."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1001\/jamaoncol.2016.0164","article-title":"Prolonged Nightly Fasting and Breast Cancer Prognosis","volume":"2","author":"Marinac","year":"2016","journal-title":"JAMA Oncol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/s41586-020-2502-7","article-title":"Fasting-mimicking diet and hormone therapy induce breast cancer regression","volume":"583","author":"Caffa","year":"2020","journal-title":"Nature"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1016\/j.biocel.2013.05.019","article-title":"Myostatin\/activin pathway antagonism: Molecular basis and therapeutic potential","volume":"45","author":"Han","year":"2013","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/jcsm.12205","article-title":"Effect of bimagrumab on thigh muscle volume and composition in men with casting-induced atrophy","volume":"8","author":"Rooks","year":"2017","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1212\/WNL.0000000000001070","article-title":"Treatment of sporadic inclusion body myositis with bimagrumab","volume":"83","author":"Amato","year":"2014","journal-title":"Neurology"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/SPC.0000000000000015","article-title":"Selective androgen receptor modulators for the prevention and treatment of muscle wasting associated with cancer","volume":"7","author":"Dalton","year":"2013","journal-title":"Curr. Opin. Support. Palliat. Care"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.eururo.2014.07.010","article-title":"Adverse effects of androgen deprivation therapy and strategies to mitigate them","volume":"67","author":"Nguyen","year":"2015","journal-title":"Eur. Urol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1152\/japplphysiol.00363.2020","article-title":"Nonuniform loss of muscle strength and atrophy during bed rest: A systematic review","volume":"131","author":"Marusic","year":"2021","journal-title":"J. Appl. Physiol."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/8\/1276\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T04:11:33Z","timestamp":1776571893000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/8\/1276"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,17]]},"references-count":135,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["cancers18081276"],"URL":"https:\/\/doi.org\/10.3390\/cancers18081276","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,17]]}}}